Use of ERC-1671 vaccine in a patient with recurrent glioblastoma multiforme after progression during bevacizumab therapy: first published report

D.A. Bota, D. Alexandru-Abrams, C. Pretto, F.M. Hofman, T.C. Chen, B. Fu, J.A. Carrillo, V.E.J.C. Schijns, A. Stathopoulos

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Use of ERC-1671 vaccine in a patient with recurrent glioblastoma multiforme after progression during bevacizumab therapy: first published report'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience